Whitepaper - Pharmaceutical Executive

ADVERTISEMENT

Whitepaper

Shift Left: Quality Assurance Best Practices

May 12, 2014

Digital quality assurance is more than checking for glitches in the code. Quality assurance is about having a system for effective communications that helps protect the value of your brand. The "Shift Left: Best Practices in Digital Healthcare Marketing" white paper contains practical principles of QA that you can apply to your current set of processes. This paper shows the collective thinking of over 50 healthcare marketing professionals from agencies and leading healthcare companies assembled to put a spotlight on quality assurance and collaborate on solutions.

What Would Alexander Graham Bell Think of Today's Contact Centers?

May 7, 2014

Who delivers your brand message to your customers? What technology do they use to create a positive customer experience for your brand? It’s not just about the phone anymore. How can creating a positive customer experience increase your brand revenue?

Elderly Representation in Clinical Trials: Not a Gray Area

May 1, 2014

Typically, clinical trials conducted in adult populations include patients between the ages of 18 and 65. But changing demographics mean such an age range is no longer broad enough. Medical decisions for those over 65 must be evidence based, which means overcoming the current “age barrier” is clinical trials. inVentiv Health Clinical examines the issue and offers suggestions for sponsors focused on improving research by reflecting changing global demographics.

Top 30 Accountable Care Organizations in the U.S.

April 29, 2014

Under Accountable Care Organizations (ACOs), decision making is highly coordinated and centralized to maximize efficiency and reduce costs. ACOs have significant control over decisions related to prescriptions, treatment, sales-rep access, and more. Download this OneKey report to identify the top 30 ACOs in the U.S. ranked by the total number of facilities and participating physicians.

Enabling Holistic, Strategic Risk-Based Monitoring

April 11, 2014

This white paper examines the current state of risk-based monitoring. It reviews the limitations of current eClinical technology to support monitoring best practices, and why sponsors and CROs are shifting to comprehensive, real-time analytics to conduct a strategic risk-based monitoring program.

When Marketing for Adherence, Don’t Ignore the Silent Majority

April 1, 2014

The importance of adherence is well recognized by industry, government, and a variety of healthcare experts. But motivating adherence is not always well understood. In this paper, inVentiv Health’s PMG shows how behavioral science, combined with online data and scientific evidence, can facilitate the behavior changes that can make a real difference to individual and public health.

Best Practices in Digital Journal App Advertising

April 1, 2014

Tablets are revolutionizing the way healthcare professionals access clinical content. Learn how digital journals are leveraging interactive learning to enhance reader experience and usage. Discover the unique advantages of journal in-app advertising. Explore practical tips and case examples that maximize the impact of multimedia content and create meaningful brand experiences.

Finding Feasibility: A Digital Discussion on Identifying Viable Products

March 25, 2014

Ken Phelps, Camargo Pharmaceutical Services president and CEO, sat down withPharmaceutical Executive to discuss identifying and pursuing the most viable products for development. In this Q&A session, Phelps shares his insight on how generics companies are overcoming the patent cliff and how Camargo goes about assessing the feasibility of drug candidates. He explains the success factors in identifying viable products that the Camargo team evaluates and how that evaluation can set the cornerstone of a time- and cost-effective development plan via the 505(b)(2) pathway. This interview will give you an inside look at how pharmaceutical companies and product developers are best preparing for the future and how you can too.

Market Profile of U.S. Oncologists

March 7, 2014

This OneKey report provides actionable insights on oncologists, an important group of specialists treating America's second deadliest disease category. Use it to formulate better marketing and engagement strategies with oncologists.

ADVERTISEMENT

Click here